|
|
|
|
|
Sponsored by: |
University of Iowa |
Information provided by: | University of Iowa |
ClinicalTrials.gov Identifier: | NCT00256412 |
This is a research study to determine whether omega-3 fatty acid supplementation, when taken with the antidepressant medication escitalopram (Lexapro), helps to improve depressive symptoms in individuals who have major depressive disorder (MDD).
Omega-3 fatty acids are found in foods including walnuts, some fruits and vegetables, and coldwater fish such as herring, mackerel, sturgeon, and anchovies.
Condition | Intervention |
Major Depression |
Drug: Eicosapentaenoic acid (EPA) 0.7 grams/day or 1.5 grams/day Drug: Placebo |
MedlinePlus related topics: | Depression |
ChemIDplus related topics: | Eicosapentaenoic acid |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Essential Fatty Acids in Management of MDD - A Pilot Study |
Enrollment: | 24 |
Study Start Date: | October 2005 |
Study Completion Date: | October 2007 |
Primary Completion Date: | October 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1: Placebo Comparator |
Drug: Placebo
4 capsules of placebo each day
|
2: Active Comparator
Low Dose
|
Drug: Eicosapentaenoic acid (EPA) 0.7 grams/day or 1.5 grams/day
Placebo and Omega 3 capsules. All participants receive 4 capsules with either 0, 2, or 4 capsules containing omega 3.
|
3: Active Comparator
High Dose
|
Drug: Eicosapentaenoic acid (EPA) 0.7 grams/day or 1.5 grams/day
Placebo and Omega 3 capsules. All participants receive 4 capsules with either 0, 2, or 4 capsules containing omega 3.
|
Show Detailed Description |
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Iowa | |||||
University of Iowa Hospitals and Clinics | |||||
Iowa City, Iowa, United States, 52242 |
University of Iowa |
Principal Investigator: | William H Coryell, M.D. | University of Iowa |
Study Director: | Jess G Fiedorowicz, M.D. | University of Iowa |
Responsible Party: | University of Iowa ( William Coryell ) |
Study ID Numbers: | IRB-01 200408033 |
First Received: | November 16, 2005 |
Last Updated: | June 3, 2008 |
ClinicalTrials.gov Identifier: | NCT00256412 |
Health Authority: | United States: Institutional Review Board |
|
|